Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03763604
Title Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Eli Lilly and Company

breast cancer



Age Groups: adult | senior
Covered Countries ITA | ESP | CAN

No variant requirements are available.